Top

Reactions Weekly

Published in:

01-07-2022 | Stem Cell Transplantion | Case report

Brexucabtagene-autoleucel

Cytokine release syndrome and immune effector cell associated neurotoxicity syndrome: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Nie E, et al. Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with CD19 CAR T-cell lymphoma therapy. Journal of Neuropathology and Experimental Neurology 81: 464, No. 6, Jun 2022. Available from: URL: http://doi.org/10.1093/jnen/nlac027 [abstract]

Title: Brexucabtagene-autoleucel
Cytokine release syndrome and immune effector cell associated neurotoxicity syndrome: case report
Publication date: 01-07-2022
Publisher: Springer International Publishing
Keywords: Stem Cell Transplantion
Status Epilepticus
Mantle Cell Lymphoma
Stem Cell Transplantation
Stem Cell Transplantation
Cytokines
Acalabrutinib
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-19132-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Brexucabtagene-autoleucel

Cytokine release syndrome and immune effector cell associated neurotoxicity syndrome: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Capecitabine

Antineoplastics

Denosumab

Ursodeoxycholic-acid

Multiple drugs

Colchicine/furosemide/methylprednisolone